| Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate CM De Jongh, MM Verberk, CET Withagen, JJL Jacobs, T Rustemeyer, ... Contact dermatitis 54 (6), 325-333, 2006 | 130 | 2006 |
| Persistent SARS-2 infections contribute to long COVID-19 JJL Jacobs Medical hypotheses 149, 110538, 2021 | 111 | 2021 |
| Local therapy of cancer with free IL-2 W Den Otter, JJL Jacobs, JJ Battermann, GJ Hordijk, Z Krastev, ... Cancer Immunology, Immunotherapy 57, 931-950, 2008 | 110 | 2008 |
| In situ crosslinked biodegradable hydrogels loaded with IL-2 are effective tools for local IL-2 therapy GW Bos, JJL Jacobs, JW Koten, S Van Tomme, T Veldhuis, ... European journal of pharmaceutical sciences 21 (4), 561-567, 2004 | 106 | 2004 |
| In vitro and in vivo protein delivery from in situ forming poly (ethylene glycol)–poly (lactide) hydrogels C Hiemstra, Z Zhong, SR Van Tomme, MJ van Steenbergen, JJL Jacobs, ... Journal of controlled release 119 (3), 320-327, 2007 | 102 | 2007 |
| Missing data is poorly handled and reported in prediction model studies using machine learning: a literature review SWJ Nijman, AM Leeuwenberg, I Beekers, I Verkouter, JJL Jacobs, ... Journal of clinical epidemiology 142, 218-229, 2022 | 94 | 2022 |
| Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration JJL Jacobs, CL Lehé, H Hasegawa, GR Elliott, PK Das Experimental dermatology 15 (6), 432-440, 2006 | 80 | 2006 |
| Effective treatment of transmissible venereal tumors in dogs with vincristine and IL2 W DEN OTTER, M Hack, JJL Jacobs, JFV Tan, L Rozendaal, ... Anticancer research 35 (6), 3385-3391, 2015 | 47 | 2015 |
| Local interleukin 2 therapy is most effective against cancer when injected intratumourally JJL Jacobs, D Sparendam, W Den Otter Cancer Immunology, Immunotherapy 54, 647-654, 2005 | 46 | 2005 |
| An automated method for the quantification of immunostained human Langerhans cells JJL Jacobs, C Lehé, KDA Cammans, K Yoneda, PK Das, GR Elliott Journal of immunological methods 247 (1-2), 73-82, 2001 | 40 | 2001 |
| Comparison of the efficacy of local treatment of equine sarcoids with IL-2 or cisplatin/IL-2 TJP Spoormakers, WR Klein, JJL Jacobs, TS Van Den Ingh, JW Koten, ... Cancer Immunology, Immunotherapy 52, 179-184, 2003 | 39 | 2003 |
| Genetic polymorphism of metabolic enzymes modifies the risk of chronic solvent-induced encephalopathy S Kezic, F Calkoen, MAM Wenker, JJL Jacobs, MM Verberk Toxicology and Industrial Health 22 (7), 281-289, 2006 | 37 | 2006 |
| Treatment of ocular squamous cell carcinomas in cattle with interleukin‐2 RJE Stewart, FWG Hill, A Masztalerz, JJL Jacobs, JW Koten, W Den Otter Veterinary Record 159 (20), 668-672, 2006 | 35 | 2006 |
| An active role for endogenous β‐1, 3‐glucanase genes in transgene‐mediated co‐suppression in tobacco M Sanders, W Maddelein, A Depicker, M Van Montagu, M Cornelissen, ... The EMBO Journal, 2002 | 35 | 2002 |
| Treatment of stage III–IV nasopharyngeal carcinomas by external beam irradiation and local low doses of IL-2 JJL Jacobs, GJ Hordijk, IM Jürgenliemk-Schulz, CHJ Terhaard, JW Koten, ... Cancer Immunology, Immunotherapy 54, 792-798, 2005 | 33 | 2005 |
| Inefficacy of therapeutic cancer vaccines and proposed improvements. Casus of prostate cancer JJL Jacobs, C Snackey, AA Geldof, D Characiejus, RJA Van Moorselaar, ... Anticancer Research 34 (6), 2689-2700, 2014 | 29 | 2014 |
| Toward rapid, widely available autologous CAR-T cell therapy–artificial intelligence and automation enabling the smart manufacturing hospital S Hort, L Herbst, N Bäckel, F Erkens, B Niessing, M Frye, N König, ... Frontiers in medicine 9, 913287, 2022 | 28 | 2022 |
| Real-time imputation of missing predictor values improved the application of prediction models in daily practice SWJ Nijman, TKJ Groenhof, J Hoogland, ML Bots, M Brandjes, ... Journal of clinical epidemiology 134, 22-34, 2021 | 27 | 2021 |
| Prediction of response in cancer immunotherapy D Characiejus, JJL Jacobs, V Pašukonienė, N Kazlauskaitė, ... Anticancer research 31 (2), 639-647, 2011 | 26 | 2011 |
| Subtoxic concentrations of allergenic haptens induce LC migration and maturation in a human organotypic skin explant culture model: a novel method for identifying potential … CL Lehé, JJL Jacobs, CM Hua, P Courtellemont, GR Elliott, PK Das Experimental dermatology 15 (6), 421-431, 2006 | 26 | 2006 |
